000			01511 a2200469 4500
005			20250513234614.0
264		0	_c20010426
008			200104s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aEvron, E
245	0	0	_aLoss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. _h[electronic resource]
260			_bCancer research _cMar 2001
300			_a2782-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aBlotting, Western
650	0	4	_aBreast _xcytology
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCarcinoma in Situ _xgenetics
650	0	4	_aCarcinoma, Ductal, Breast _xgenetics
650	0	4	_aCpG Islands
650	0	4	_aCyclin D2
650	0	4	_aCyclins _xbiosynthesis
650	0	4	_aDNA Methylation
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGene Silencing
650	0	4	_aHumans
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
700	1		_aUmbricht, C B
700	1		_aKorz, D
700	1		_aRaman, V
700	1		_aLoeb, D M
700	1		_aNiranjan, B
700	1		_aBuluwela, L
700	1		_aWeitzman, S A
700	1		_aMarks, J
700	1		_aSukumar, S
773	0		_tCancer research _gvol. 61 _gno. 6 _gp. 2782-7
999			_c11224454 _d11224454